Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 3
2013 9
2014 4
2015 9
2016 17
2017 18
2018 24
2019 28
2020 41
2021 28
2022 31
2023 41
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Reply.
Buisson A, Nachury M, Fumery M. Buisson A, et al. Among authors: fumery m. Clin Gastroenterol Hepatol. 2023 Aug;21(9):2431-2432. doi: 10.1016/j.cgh.2022.11.006. Epub 2022 Nov 17. Clin Gastroenterol Hepatol. 2023. PMID: 36402373 No abstract available.
Reply.
Yzet C, Brazier F, Fumery M. Yzet C, et al. Among authors: fumery m. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2214-2215. doi: 10.1016/j.cgh.2020.11.016. Epub 2020 Nov 16. Clin Gastroenterol Hepatol. 2021. PMID: 33212207 No abstract available.
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.
Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, D'Haens G, Picon L, Bossuyt P, Vuitton L, Irving P, Viennot S, Lamb CA, Pollok R, Baert F, Nachury M, Fumery M, Gilletta C, Almer S, Ben-Horin S, Bouhnik Y, Colombel JF, Hertervig E; GETAID and the SPARE-Biocycle research group. Louis E, et al. Among authors: fumery m. Lancet Gastroenterol Hepatol. 2023 Mar;8(3):215-227. doi: 10.1016/S2468-1253(22)00385-5. Epub 2023 Jan 11. Lancet Gastroenterol Hepatol. 2023. PMID: 36640794 Free PMC article. Clinical Trial.
Reply.
Yzet C, Fumery M. Yzet C, et al. Among authors: fumery m. Clin Gastroenterol Hepatol. 2022 Mar;20(3):e641-e642. doi: 10.1016/j.cgh.2021.07.007. Epub 2021 Jul 3. Clin Gastroenterol Hepatol. 2022. PMID: 34229039 No abstract available.
[Gastric mucosal calcinosis].
Dréau A, Lecomte A, Ronfaut A, Matias C, Fumery M, Chatelain D. Dréau A, et al. Among authors: fumery m. Ann Pathol. 2022 Jan;42(1):89-91. doi: 10.1016/j.annpat.2021.06.009. Epub 2021 Dec 16. Ann Pathol. 2022. PMID: 34924222 French.
203 results